OXAZOLIDINONE HYDROXAMIC ACID DERIVATIVES

    公开(公告)号:US20210238151A1

    公开(公告)日:2021-08-05

    申请号:US17145357

    申请日:2021-01-10

    Abstract: Oxazolidione hydroxamic acid derivatives of the general formula (I): where R1 is hydrogen or hexanoyl and R2 is amino, methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, cyclobutyl, pentyl, cyclopentyl, hexyl or heptyl, and pharmaceutically acceptable salts thereof, act as dual inhibitors of 5-lipoxygenase and mast cell degranulation. The oxazolidinone hydroxamic acid derivatives or pharmaceutically acceptable salts thereof can be used in the prevention and treatment of asthma and allergies, as well as inflammatory conditions.

    CONFINED PLUNGING LIQUID JET REACTOR WITH MODIFIED DOWNCOMER

    公开(公告)号:US20200330934A1

    公开(公告)日:2020-10-22

    申请号:US16386219

    申请日:2019-04-16

    Abstract: The confined plunging liquid jet reactor with modified downcomer includes a downcomer having an upper end, an open lower end, and a gas inlet for receiving gas. A plurality of longitudinally-extending baffles and/or a sieve are mounted in the downcomer, adjacent the open lower end thereof. A nozzle is mounted on the upper end of the downcomer for receiving a pressurized liquid from an external source to generate a liquid jet. The liquid jet impinges on liquid contained within the downcomer creating turbulence and bubbles with the gas entrained therein. The open lower end of the downcomer is positioned within a receiving tank holding a reservoir of the liquid such that a portion of the mixture of the liquid and the gas exits the open lower end of the downcomer to flow into the receiving tank.

    SMALL ANIMAL RESISTANCE EXERCISE SYSTEM
    43.
    发明申请

    公开(公告)号:US20190124883A1

    公开(公告)日:2019-05-02

    申请号:US15801157

    申请日:2017-11-01

    CPC classification number: A01K1/035 A01K1/031 A01K1/0613 A01K15/027

    Abstract: A system for examining resistance exercise includes a first trap compartment, a second trap compartment, a main track compartment and a pulley system which can be aligned to form a continuous tunnel. Each of the compartments can have adjustable dimensions to retain small animals of various sizes. The pulley system includes a clamp and a pulley shaft. The pulley shaft is pivotally attached to the clamp at a lower end and a first pulley wheel at an upper end. A second pulley wheel is pivotally attached to the clamp. A rope is trained on the pulley wheels. The tunnel can be positioned on an elevated support surface. One end of the rope is attachable to a rat on the elevated support surface and the other end of the rope is to attached to liftable strength training objects positioned below the elevated support surface.

    MINIMIZING TWO-STEP AND HARD STATE TRANSITIONS IN MULTI-LEVEL STT_MRAM DEVICES

    公开(公告)号:US20190103150A1

    公开(公告)日:2019-04-04

    申请号:US15724075

    申请日:2017-10-03

    CPC classification number: G11C11/1675 G11C7/1006 G11C11/1653 G11C11/5607

    Abstract: Data is stored in a multi-level MRAM (MLC MRAM) cell in a manner that reduces transition states that require high energy. A new data block is received, and the new data block is divided into one or more sub-groups of bits, with each sub-group comprising at least two bits. Each sub-group is assigned data bit locations in a memory store. The received bits are compared with sub-groups present at the data bit locations to determine subgroups of hot bits. For each subgroup of hot bits, an encoding flag value is determined by XORing their most significant bits. The most significant bits of each subgroup of hot bits are complemented and the encoding flag is SET. A data block is generated to establish a data group for each subgroup of hot bits including the subgroup of hot bits and the encoding flag for that subgroup.

    Method of treating delayed healing of a wound associated with diabetes

    公开(公告)号:US10206896B2

    公开(公告)日:2019-02-19

    申请号:US16020517

    申请日:2018-06-27

    Abstract: The method of treating delayed healing of a wound associated with diabetes includes administering to the wound a composition comprising an anti-senescence compound and a pharmaceutically acceptable carrier. The anti-senescence compound may be 18α-Glycyrrhetinic acid, a Caveolin-1 (Cav-1) inhibitory compound, or a Polymerase I Transcript Release Factor (PTRF-1) inhibitory compound. The anti-senescence compound may be effective in preventing and/or reversing premature cellular senescence. The anti-senescence compound may be effective in promoting healing of a wound, e.g., delayed or incompletely healed wound. The anti-senescence compound may be effective in promoting healing of a delayed healing wound or chronic wound of a diabetic patient, such as a diabetic ulcer or venous ulcer.

    Cooling system for patients with fever

    公开(公告)号:US10045880B2

    公开(公告)日:2018-08-14

    申请号:US15003739

    申请日:2016-01-21

    Abstract: The cooling system for patients with fever is a mechanical, fluid-based system for cooling patients suffering from fever. The cooling system for patients with fever includes a reservoir for containing a cooling fluid, which is maintained at a desired temperature. A temperature sensor is received in the reservoir. The temperature sensor is immersed in the cooling fluid for measuring the temperature thereof. A chiller is also received in the reservoir for selectively cooling the cooling fluid when the temperature thereof, measured by the temperature sensor, is above a pre-set temperature threshold. The reservoir communicates with a cooling pad, which is formed from a padded layer having at least one channel embedded therein. At least one pump and tubing is provided for circulating the cooling fluid through the reservoir and the cooling pad. In use, the cooling pad is applied to the skin of a patient with a fever.

    System and method for determining the feedback capacity of information distributed in a complex network

    公开(公告)号:US09904961B2

    公开(公告)日:2018-02-27

    申请号:US14706940

    申请日:2015-05-07

    CPC classification number: G06Q50/01 H04L41/145 H04L41/16

    Abstract: The system and method for determining the feedback capacity of information distributed in a complex network determines feedback capacity as information is received and diffused throughout the network. Traditionally, real networks, such as computer networks, were used in determining network feedback. However, current complex networks typically incorporate graphing models for network analysis. The system and method provide a process to determine the quality of a complex network with respect to feedback capacity, such as can be determined by a corresponding Belief Propagation algorithm and a corresponding entropy equation. The system and method can also determine the cyclic entropy per penetration in a complex network, the depth penetration for nodes in the complex network and a plurality of cycle counts per node in the complex network based on a source node.

    METHOD OF TREATING DELAYED HEALING OF A WOUND ASSOCIATED WITH DIABETES
    50.
    发明申请
    METHOD OF TREATING DELAYED HEALING OF A WOUND ASSOCIATED WITH DIABETES 审中-公开
    治疗与糖尿病相关的延迟疗法的方法

    公开(公告)号:US20150352064A1

    公开(公告)日:2015-12-10

    申请号:US14301301

    申请日:2014-06-10

    Abstract: The method of treating delayed healing of a wound associated with diabetes includes administering to the wound a composition comprising an anti-senescence compound and a pharmaceutically acceptable carrier. The anti-senescence compound may be 18α-Glycyrrhetinic acid, a Caveolin-1 (Cav-1) inhibitory compound, or a Polymerase I Transcript Release Factor (PTRF-1) inhibitory compound. The anti-senescence compound may be effective in preventing and/or reversing premature cellular senescence. The anti-senescence compound may be effective in promoting healing of a wound, e.g., delayed or incompletely healed wound. The anti-senescence compound may be effective in promoting healing of a delayed healing wound or chronic wound of a diabetic patient, such as a diabetic ulcer or venous ulcer.

    Abstract translation: 治疗与糖尿病相关的伤口的延迟愈合的方法包括向伤口施用包含抗衰老化合物和药学上可接受的载体的组合物。 抗衰老化合物可以是18α-甘草次酸,窖蛋白-1(Cav-1)抑制化合物或聚合酶I转录物释放因子(PTRF-1)抑制化合物。 抗衰老化合物可以有效预防和/或逆转过早的细胞衰老。 抗衰老化合物可有效促进伤口愈合,例如延迟或不完全愈合的伤口。 抗衰老化合物可有效促进糖尿病患者如糖尿病性溃疡或静脉溃疡的延迟愈合伤口或慢性伤口的愈合。

Patent Agency Ranking